Business
Canopy Growth is a cannabis company with cannabis revenue and Storz & Bickel vaporizer revenue rows.
Canopy narrowed losses, but cash flow and margins remained negative.
The read at a glance✓ Audited against SEC data
- Business mix — Cannabis and Storz & BickelNote
- Revenue — $284.60M, +5.8%OK
- Net income — ($262.91M), improved 48.3%OK
- FCF — ($69.14M), still negativeWatch
- Debt — $233.36M, -23.3%OK
- Altman/Beneish/EQ — Low Z; M no flag; EQ safeNote
- Insiders — 1 purchase / 21 salesNote
Where the revenue comes from
Fiscal 2026, as Canopy Growth Corp reports it. History and quarterly detail are in the app.
- Canadian Adult Use CannabisCAD 94.5M
- Canadian Medical CannabisCAD 90.8M
- Storz BickelCAD 70.7M
- International Markets CannabisCAD 28.7M
Leadership changes
From Canopy Growth Corp's own filings, the day they're filed.
- Thomas Stewart · Chief Financial Officer · appointmenteff. 2025-09-17
- Judy Hong · departureeff. 2025-07-09
- Luc Mongeau · Chief Executive Officer · appointmenteff. 2025-01-06
Latest filings
- DEF 14A · Annual proxy (pay & governance)2026-08-07
- 8-K · Company announcement2026-08-07
- 10-Q · Quarterly report2026-08-07
- 8-K · Company announcement2026-08-07
- 8-K · Company announcement2026-06-15
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Canopy Growth Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.